FcγRIIB engagement drives agonistic activity of Fc-engineered αOX40 antibody to stimulate human tumor-infiltrating T cells.
Campos Carrascosa L, van Beek AA, de Ruiter V, Doukas M, Wei J, Fisher TS, Ching K, Yang W, van Loon K, Boor PPC, Rakké YS, Noordam L, Doornebosch P, Grünhagen D, Verhoef K, Polak WG, IJzermans JNM, Ni I, Yeung YA, Salek-Ardakani S, Sprengers D, Kwekkeboom J.
Campos Carrascosa L, et al. Among authors: verhoef k.
J Immunother Cancer. 2020 Sep;8(2):e000816. doi: 10.1136/jitc-2020-000816.
J Immunother Cancer. 2020.
PMID: 32900860
Free PMC article.